About this trial
This study aims to evaluate the effectiveness of the tent pole technique in vertical peri-implant soft tissue augmentation and to assess its impact on marginal bone loss. Additionally, the adjunctive use of platelet-rich fibrin and photobiomodulation will be explored to determine their influence on the clinical outcomes of this procedure.
Eligibility criteria
Qualifiers
Participants must be over 18 years of age. They should be legally capable of adhering to study protocols, which include maintaining proper oral hygiene, attending all scheduled follow-up visits, fully understanding the proposed surgical procedures, and signing the informed consent form.
single edentulous sites in the premolar and/or molar region of the mandible.
Vertical gingival thickness must be more than 1 mm and less than or equal to 2 mm.
A minimum of 2 mm of attached gingiva should be present on both the buccal and lingual sides of the implant sites.
Disqualifiers
Presence of general contraindications for dental implants or surgical interventions.
Heavy smoking, defined as more than 10 cigarettes daily, including pipe, vape or cigar use.
Poor oral hygiene, characterized by probing depths greater than 4 mm in adjacent teeth, and a full mouth plaque score (FMPS) or full mouth bleeding score (FMBS) exceeding 25% after the pre-treatment phase.
Guided bone regeneration at the implant site.
Trial design
Treatments tested in this trial
- VST augmentation with TPT
- TPT-PRF
- TPT-PBM
- Group control: implant placement without TPT
Treatment groups
Sponsors and collaborators
University of Santiago de Compostela
Lead sponsor
Galimplant Dental Implants
Collaborator